Inhibikase Therapeutics (IKT) Stock Chart & Stock Price History → It's time to ween off Chinese lithium! (From Smallcaps Daily) (Ad) Free IKT Stock Alerts $1.69 +0.03 (+1.81%) (As of 06/7/2024 08:52 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Inhibikase Therapeutics Stock Price Performance5 Day Performance-2.31%1 Month Performance+29.01%3 Month Performance-31.58%6 Month Performance+36.29%Year-To-Date Performance+33.07%1 Year Performance-58.84% Receive IKT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inhibikase Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Oasis GoldExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of opportunity to protect your interests is closing fast.Click Here To Get Your FREE Guide Now! IKT Stock Chart for Monday, June, 10, 2024 IKT Chart by TradingView Inhibikase Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/07/2024$1.72$1.69-1.74%$1.70$1.6113,441 shs$10.95 million06/06/2024$1.73$1.72-0.58%$1.83$1.5025,626 shs$11.15 million06/05/2024$1.82$1.73-4.69%$1.82$1.7334,994 shs$11.21 million06/04/2024$1.86$1.82-2.41%$1.92$1.6428,958 shs$11.76 million06/03/2024$1.84$1.86+1.09%$1.92$1.7810,632 shs$12.05 million05/31/2024$1.81$1.84+1.66%$1.89$1.8233,340 shs$11.92 million Get the Latest News and Ratings for IKT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inhibikase Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/30/2024$1.81$1.81$1.84$1.8014,250 shs$11.72 million05/29/2024$1.76$1.81+2.84%$1.82$1.8019,576 shs$11.73 million05/28/2024$1.81$1.76-2.76%$1.84$1.6520,639 shs$11.41 million05/27/2024$1.81$1.81$1.90$1.7533,000 shs$11.73 million05/24/2024$1.83$1.81-1.09%$1.90$1.7533,047 shs$11.73 million05/23/2024$1.86$1.83-1.35%$1.89$1.7728,327 shs$11.86 million05/22/2024$1.89$1.86-1.85%$1.91$1.7329,703 shs$12.02 million05/21/2024$1.86$1.89+1.61%$1.92$1.7736,881 shs$12.25 million05/20/2024$1.73$1.86+7.51%$1.90$1.63118,995 shs$12.05 million05/17/2024$1.76$1.73-1.70%$1.88$1.7246,753 shs$11.21 million05/16/2024$1.99$1.76-11.56%$1.97$1.6991,983 shs$11.40 million05/15/2024$1.52$1.99+30.92%$2.22$1.55564,392 shs$12.90 million05/14/2024$1.36$1.52+11.76%$1.60$1.3648,090 shs$9.85 million05/13/2024$1.31$1.36+3.82%$1.40$1.309,931 shs$8.81 million05/10/2024$1.36$1.31-3.68%$1.44$1.3055,165 shs$8.49 million05/09/2024$1.40$1.36-2.86%$1.39$1.3534,612 shs$8.81 million05/08/2024$1.26$1.40+11.11%$1.55$1.3134,551 shs$9.07 million05/07/2024$1.29$1.26-2.33%$1.30$1.2030,515 shs$8.17 million05/06/2024$1.39$1.29-7.19%$1.45$1.2971,291 shs$8.36 million05/03/2024$1.34$1.39+3.73%$1.51$1.3346,964 shs$9.01 million05/02/2024$1.35$1.34-0.74%$1.40$1.2969,386 shs$8.68 million05/01/2024$1.47$1.35-8.16%$1.45$1.3594,289 shs$8.74 million04/30/2024$1.59$1.47-7.55%$1.60$1.4355,165 shs$9.53 million04/29/2024$1.71$1.59-7.02%$1.76$1.5940,155 shs$10.30 million04/26/2024$1.86$1.71-8.06%$1.82$1.6798,983 shs$11.08 million04/25/2024$1.87$1.86-0.53%$1.90$1.7121,378 shs$12.05 million04/24/2024$1.58$1.87+18.35%$1.87$1.5462,107 shs$12.12 million04/23/2024$1.37$1.58+15.33%$1.60$1.4479,090 shs$10.24 million04/22/2024$2.04$1.37-32.84%$1.96$1.29367,713 shs$8.88 million04/19/2024$2.10$2.04-2.86%$2.13$2.0252,727 shs$13.22 million04/18/2024$2.13$2.10-1.41%$2.15$2.0427,598 shs$13.61 million04/17/2024$2.16$2.13-1.39%$2.20$2.1137,008 shs$13.80 million04/16/2024$2.20$2.16-1.59%$2.30$2.1312,949 shs$14.00 million04/15/2024$2.19$2.20+0.23%$2.25$2.1427,860 shs$14.22 millionExecutive Order To Wipe Out Your Bank Accounts (Ad)Don't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of opportunity to protect your interests is closing fast.Click Here To Get Your FREE Guide Now!04/12/2024$2.25$2.19-2.67%$2.22$2.1531,317 shs$14.19 million04/11/2024$2.19$2.25+2.74%$2.25$2.1524,619 shs$14.58 million04/10/2024$2.13$2.19+2.82%$2.20$2.0928,732 shs$14.19 million04/09/2024$2.21$2.13-3.62%$2.20$2.0524,120 shs$13.80 million04/08/2024$2.20$2.21+0.45%$2.29$2.1534,726 shs$14.32 million04/05/2024$2.20$2.20$2.27$2.1542,009 shs$14.26 million04/04/2024$2.15$2.20+2.33%$2.27$2.1550,804 shs$14.26 million04/03/2024$2.15$2.15$2.28$2.0926,489 shs$13.93 million04/02/2024$2.16$2.15-0.46%$2.29$2.1246,468 shs$13.93 million04/01/2024$2.16$2.16$2.28$2.0167,763 shs$14.00 million03/29/2024$2.16$2.16$2.44$2.0897,891 shs$13.33 million03/28/2024$2.30$2.16-6.09%$2.44$2.0897,781 shs$13.33 million03/27/2024$2.29$2.30+0.44%$2.32$2.2514,636 shs$14.19 million03/26/2024$2.21$2.29+3.62%$2.39$2.2140,390 shs$14.13 million03/25/2024$2.23$2.21-0.90%$2.35$2.2030,251 shs$13.64 million03/22/2024$2.21$2.23+0.90%$2.25$2.1418,974 shs$13.76 million03/21/2024$2.05$2.21+7.80%$2.30$1.9250,973 shs$13.64 million03/20/2024$1.93$2.05+6.22%$2.10$1.9171,762 shs$12.65 million03/19/2024$2.01$1.93-3.98%$2.02$1.8175,747 shs$11.91 million03/18/2024$2.11$2.01-4.74%$2.17$1.9689,529 shs$12.40 million03/15/2024$2.13$2.11-0.94%$2.21$2.0536,505 shs$13.02 million03/14/2024$2.23$2.13-4.48%$2.30$2.1147,591 shs$13.15 million03/13/2024$2.27$2.23-1.76%$2.35$2.2129,315 shs$13.77 million03/12/2024$2.43$2.27-6.58%$2.42$2.1147,513 shs$14.01 million03/11/2024$2.47$2.43-1.62%$2.46$2.2937,130 shs$14.99 million Related Companies: ALGS Stock Price Chart OKYO Stock Price Chart ACHL Stock Price Chart CYTH Stock Price Chart QNCX Stock Price Chart NKGN Stock Price Chart SRZN Stock Price Chart ESLA Stock Price Chart INKT Stock Price Chart PLUR Stock Price Chart Receive IKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inhibikase Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:IKT) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersAlert: Your Bank is Dying – Act Now or Lose Everything!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put...Priority Gold | SponsoredTrump convicted... now what?Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inhibikase Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inhibikase Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.